La Jolla, CA (PRWEB) November 07, 2013
Currently there is no cure for MS, but stem cell treatment studies like the ones being offered through StemGenex attempt to slow the progression of the disease and limit its symptoms or complications. Since adult stem cells have the ability to differentiate into many different types of cells, such as those required for proper functioning and protection of nerve cells, the use of adult stem cells for MS could be of substantial value.
StemGenex is currently studying ways to more effectively deliver these adult stem cells directly to the areas of the body that need them most. One of these groundbreaking treatments is called intranasal stem cell administration which highlights the potential for a noninvasive approach to cell therapy delivery. This approach poses itself as a much safer and effective alternative to surgical brain transplantation of stem cells. Intranasal administration works by providing mesenchymal stem cells a pathway to travel through the nose to the brain, past the blood brain barrier. It also makes it possible to deliver multiple treatments over time.
Stem cell treatment studies are currently being offered by StemGenex patients diagnosed with Multiple Sclerosis and other degenerative neurological diseases. StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative diseases including Parkinson’s, Alzheimer’s disease, stroke recovery, COPD and others. Rita Alexander, founder of StemGenex and the company’s first stem cell patient, insists that all patients be treated like they are one of our loved ones. “Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus.”
To find out more about stem cell therapy, contact StemGenex either by phone at (800) 609-7795 or email Contact(at)stemgenex(dot)com.